BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2275274)

  • 1. [Various aspects of production of a therapeutic form of liposomal cytarabine].
    Pleteneva OP; Oksinoĭd OE; Afonin NI
    Vestn Akad Med Nauk SSSR; 1990; (8):33-4. PubMed ID: 2275274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems of the preparation and control of properties of sterile drug-containing liposomes].
    Trofimov VI; Nisnevich MM
    Vestn Akad Med Nauk SSSR; 1990; (6):28-32. PubMed ID: 2220033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ectericide as a dispersion medium for the preparation of prospective clinical liposomal drug forms].
    Dikiĭ IL; Strel'nikov LS; Chueshov VI; Iakovenko VD; Bazavluk AD
    Vestn Akad Med Nauk SSSR; 1990; (6):40-4. PubMed ID: 2220037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on liposome preparation technique of Bupleurum chinense volatile oil for injection].
    Yu YH; Li XC; Wu T; Tu PF
    Zhongguo Zhong Yao Za Zhi; 2004 Jun; 29(6):521-5. PubMed ID: 15706913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trends in the development of research in the field of liposomes (review of patent literature)].
    Nesytova NIu; Paleva NS; Il'ina EV; Shenk P; Bendas F; Nun P
    Vestn Akad Med Nauk SSSR; 1990; (6):8-19. PubMed ID: 2220043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin.
    Dicko A; Kwak S; Frazier AA; Mayer LD; Liboiron BD
    Int J Pharm; 2010 May; 391(1-2):248-59. PubMed ID: 20156541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biotechnological and biomedical aspects of production and study of metal cation-phospholipid complexes].
    Omel'chenko AM; Bovykin BA; Shkola OI; Ryshka F; Sosada M
    Vestn Akad Med Nauk SSSR; 1990; (8):27-9. PubMed ID: 2275272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elaboration of the technology of producing a lyophilized form of immunoglobulin preparations for intravenous administration].
    Kiseleva IA; Anastasiev VV; Novikova LP; Voronova EA; Kartavina GIu
    Gematol Transfuziol; 1990 May; 35(5):32-4. PubMed ID: 2394359
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
    Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
    J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facile microfluidic method for production of liposomes.
    Pradhan P; Guan J; Lu D; Wang PG; Lee LJ; Lee RJ
    Anticancer Res; 2008; 28(2A):943-7. PubMed ID: 18507040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale production of lipoplexes with long shelf-life.
    Clement J; Kiefer K; Kimpfler A; Garidel P; Peschka-Süss R
    Eur J Pharm Biopharm; 2005 Jan; 59(1):35-43. PubMed ID: 15567299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
    Budai M; Szógyi M
    Acta Pharm Hung; 2001; 71(1):114-8. PubMed ID: 11769091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [All-Union program "Liposomes and their use in biology and medicine" (the research and research-practice parts of the program)].
    Vestn Akad Med Nauk SSSR; 1990; (6):4-7. PubMed ID: 2220036
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.
    Spyratou E; Mourelatou EA; Makropoulou M; Demetzos C
    Expert Opin Drug Deliv; 2009 Mar; 6(3):305-17. PubMed ID: 19327046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a liposome preparation by a pH-gradient method.
    Vemuri S; Rhodes CT
    J Pharm Pharmacol; 1994 Oct; 46(10):778-83. PubMed ID: 7699562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse.
    Bayne WF; Mayer LD; Swenson CE
    J Pharm Sci; 2009 Jul; 98(7):2540-8. PubMed ID: 19009594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of the development of liposomal dosage forms of antibiotics].
    Berezovskaia LN; Griaznova NS; Bairamashvili DI; Iarotskiĭ SV
    Antibiot Khimioter; 1990 Oct; 35(10):31-5. PubMed ID: 2278496
    [No Abstract]   [Full Text] [Related]  

  • 20. Liposomal cytarabine: new drug. Lymphomatous meningitis: no better than standard cytarabine.
    Prescrire Int; 2006 Feb; 15(81):11-2. PubMed ID: 16548098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.